Clinical Trials Supplies Market Trends

1. 1

2. 2 2 Clinical Trials Supplies Market Trends Clinical Trials Supplies Market Trends Clinical trial supplies Clinical trial supplies include all products and services we need to conduct clinical trials. These products and services in the form of supply chain management and transportation of various biologics, pharmaceutical products, and medical devices. On the basis of phases phase I: the initial phase which include studies assessing the safety of a drug or device phase II: studies which determine the efficacy of a drug or device phase III: one of the most critical phases assessing the effectiveness of the new intervention, as well as its value in clinical practice. Most of Phase III clinical trials can be marketed FDA norms, through approval of a New Drug Application (NDA) containing all manufacturing, pre-clinical, and clinical data. The number of patients is huge and varied between 300-3000, and in several cases much higher. And as per the clinicaltrials.gov, there were around 5800 active studies ongoing in 2018; the United States and some European countries had the most number of clinical trials, followed by China and Canada. The Middle East, Australia, and Japan are the regions with a significant number of clinical trials being conducted. On the Clinical Trials Supplies Market Trends Clinical Trials Supplies Market Trends

3. 3 3 On the basis of therapeutic areas, the market has been segmented into oncology, cardiovascular and metabolic disorders, infectious diseases, blood disorders, respiratory diseases, otorhinolaryngology diseases, CNS and mental disorders, dermatology disorders, and others. The oncology segment is fastest growing and account for the largest share of the global market in 2018. On the basis of region this market is mainly spread across North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, North America hold the leading position with maximum market share in the global clinical trial supply and logistics market due its strong medical infrastructure. Besides many organizations are growing in this sector in North America owing to the availability of necessary funds, mainly to conduct research and develop new and efficient treatments using clinical trials. Moreover, adoption of technologically advanced products as well as rising number of regulatory agencies is also making the market in North America account for maximum revenue. However, Asia pacific is likely to surpass others in terms of market growth in the near future and that is due to the rising cases of various medical conditions that demand use of new treatments. With numerous well-known players expanding their presence in Asian economies such as china and India pushing the global clinical trial supply and logistics market in Asia to progress at asteady pace. Clinical Trials Supplies Market Trends Clinical Trials Supplies Market Trends

4. 4 4 Global clinical trial supplies market Global clinical trial supplies market The global clinical trial supplies market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6% according to a market research report done in 2018. CAGR exceeds the previous reported one in 2015 by about 5 %. Owning mainly to rising number of clinical trials and significant partnerships between biopharma companies and CROs. The logistics and distribution segment accounts for the largest share of the global clinical trial supplies products market. Europe clinical trial market Europe is the second biggest market in terms of market share in the global clinical trials market The European clinical trials market is expected to register a CAGR of 5.1% over the forecast period. Factors that are responsible for the growth of this market include high R&D spending of the pharmaceutical industry and increasing prevalence of diseases. Global clinical trials supplies Market: Growth Factors Rise in the occurrence of chronic diseases such as HIV, cancer, and epilepsy is the key factor for the strong market growth. The demand in the market is increasing to outsource the drug discovery services and stress is being made to determine the toxicity level in Clinical Trials Supplies Market Trends Clinical Trials Supplies Market Trends

5. 5 5 early stages of drug discovery, this may give rise to the market growth. Increasing emphasis on R&D in various countries coupled with rising government funding for development of new drugs in anticipated to boost the growth of the market. New entrants in the market are focusing on launching new products and adopting new technologies. This is influencing the market in a positive way. Lack of infrastructure and inadequate trained professionals are the factors that are restraining the clinical trial supplies market to some extent. Global Clinical Trial Supply and Logistics Market: Competitive entiti Global Clinical Trial Supply and Logistics Market: Competitive entities es This market witnesses the presence of a substantially competitive entities, with the presence of expertise players exerting dominance. achieving geographical expansion, steady growth of the market as (Catalent Pharma Solutions, Inc., Almac Group, Patheon, Movianto, Inc., PCI Pharma Distribution, Sharp Packaging Distribution, Marken, PAREXEL International Corporation, KLIFO A/S, and Biocair) are some of the key players operating in the global clinical trial supply and logistics market. With increasing number of players in the near future, the competition is likely to further intensify. Clinical Trials Supplies Market Trends Clinical Trials Supplies Market Trends